Enhance your practice with CME and tools that focus on diseases and conditions impacting the female patient.
Target Locked in gMG: Why T2T Matters
Christyn Edmundson, MD
Gil I. Wolfe MD, FAAN
FcRn: Same Class, Different Paths—Spot Agent Differentiators
Scorecards That Matter: Use MG-ADL, MG-MMT, QMG, QoL
Turning Flares Into Function: Flag Uncontrolled Disease
Treat. Target. Transform: Applying Treat-to-Target Principles in the Management of Generalized Myasthenia Gravis (gMG)
The 2-Point Signal: Apply ≥2-Point Rule
ENDOVOICE Live: Endometriosis—A Chronic Burden of Reproductive Years
Linda Bradley, MD
Obianuju Sandra Madueke-Laveaux, MD, MPH
Lauren R. Kornegay
Primary Biliary Cholangitis: Shining Light on an "Invisible" Female Health Burden
Gideon Hirschfield, MB, BChir, PhD
Marlyn Mayo, MD
Precision Starts Before Birth: Reimagining Fetal Care Through FcRn Immune Modulation
Kenneth J. Moise Jr., MD
Kara B. Markham, MD
Not Just a Headache: Migraine Across Women’s Lifespan
Jelena Pavlović, MD, PhD
Amaal J. Starling, MD, FAHS, FAAN
Women’s Sleep Health – Addressing Gaps in OSA Diagnosis and Treatment Across Life Stages
Alison Kole, MD, MPH, FACCP
Ghada Bourjeily, MD, FCCP
Rashmi Nisha Aurora, MD
Audrey Wells, MD
The Alloimmune Disorders of Pregnancy
Karin J. Blakemore, MD
Emilie L. Vander Haar
Cut to the Chase: Why Not Treat Endometriosis With GnRH Antagonists First?
Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP
Sawsan As-Sanie, MD
James A. Simon, MD, CCD, NCMP, IF, FACOG
Changing the Mindset in the Management of Endometriosis: Hitting the Pause Button on Surgical Procedures and Expanding the Role of GnRH Antagonists
Lee P. Shulman, MD, FACMG, FACOG
Melissa Simon, MD
Samantha Denäe
Casey Joe Hinds
Early Diagnosis: Its Pivotal Role in Optimizing Outcomes in Patients With Endometriosis – Psychosocial and Physical Consequences
It’s Not Just Black and White: Seeing the Full Spectrum of Endometriosis Cases
When to Begin FcRn: Initiation Criteria, Key Evidence
Diagnosing and Treating IBS: It Begins With One Simple Question
Brooks D. Cash, MD, AGAF, FACG, FACP, FASGE
Kimberly D. Orleck, PA-C
Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT): Overcoming Diagnostic and Therapeutic Challenges
Clinical Considerations for the Diagnosis of Endometriosis
Changing the Paradigm in the Management of Endometriosis: Moving Away From “Surgery First” to “Pharmacologic Therapy First”
Capturing the Impact of Endometriosis on Health-Related QoL: The Role of Patient Questionnaires
Why Are the Fetus and Placenta Not Rejected by the Mother? New Insights Into Maternal Anti-Fetal Rejection
Roberto Romero, MD, DMedSci
Parallels Between Kidney Transplantation and Maternal Anti-Fetal Rejection
Alexandra Benachi, MD, PhD
Julien Zuber, MD, PhD
Minimal By Design: Define MSE Endpoints
The IgG Clock: Redose Using IgG Kinetics
Can We Talk? Optimizing Patient Buy-In to the Management of Endometriosis
The Integral Role of GnRH Antagonists in the Management of Endometriosis
Strategies to Address Healthcare Disparities in Patients With Endometriosis
Alloimmune Thrombocytopenia in the Fetus and Newborn
James B. Bussel, MD
Red Blood Cell Alloimmunization, Pathophysiology, Diagnosis, Treatment, and Prevention
Travel for IBD Patients: How to Help Them Prepare
Adam Ehrlich, MD, MPH
Adam Kaufman, MD
Loading...
We're glad to see you're enjoying Omnia Education… but how about a more personalized experience?
Press cancel to remain on Omnia Education. Press the link below or the continue button to keep going.